Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Depression associated with diltiazem.

Literature DB >> 2508936

Depression associated with diltiazem.

C Biriell¹, J McEwen, E Sanz.

Abstract

Entities: Chemical Disease

Mesh：

Substances：
Diltiazem

Year: 1989 PMID： 2508936 PMCID： PMC1837613 DOI： 10.1136/bmj.299.6702.796

Source DB: PubMed Journal: BMJ ISSN： 0959-8138

× No keyword cloud information.

11 in total

1. Organic psychosis caused by diltiazem.

Authors: C J Busche
Journal: J R Soc Med Date: 1988-05 Impact factor: 5.344

2. A case of Tourette syndrome treated with nifedipine.

Authors: R Berg
Journal: Acta Psychiatr Scand Date: 1985-10 Impact factor: 6.392

3. Diltiazem for tardive dyskinesia and tardive dystonia.

Authors: W E Falk; J D Wojick; A J Gelenberg
Journal: Lancet Date: 1988-04-09 Impact factor: 79.321

4. Parkinsonism, tardive dyskinesia, akathisia, and depression induced by flunarizine.

Authors: R H Meyboom; M D Ferrari; B P Dieleman
Journal: Lancet Date: 1986-08-02 Impact factor: 79.321

5. Nifedipine-induced acute psychosis.

Authors: S Ahmad
Journal: J Am Geriatr Soc Date: 1984-05 Impact factor: 5.562

6. Diltiazem and akathisia.

Authors: M B Jacobs
Journal: Ann Intern Med Date: 1983-12 Impact factor: 25.391

7. Nifedipine-associated acute psychosis.

Authors: J K Kahn
Journal: Am J Med Date: 1986-10 Impact factor: 4.965

Review 8. Migraine treatment with calcium channel blockers.

Authors: K E Andersson; L Brandt; B Hindfelt; T Ryman
Journal: Acta Pharmacol Toxicol (Copenh) Date: 1986

9. Depression associated with nifedipine-induced calcium channel blockade.

Authors: F J Hullett; S G Potkin; A B Levy; R Ciasca
Journal: Am J Psychiatry Date: 1988-10 Impact factor: 18.112

10. Parkinsonism, tardive dyskinesia, akathisia, and depression induced by flunarizine.

Authors: C Chouza; A Scaramelli; J L Caamaño; O De Medina; R Aljanati; S Romero
Journal: Lancet Date: 1986-06-07 Impact factor: 79.321

11 in total

1. Risk of suicide in users of beta-adrenoceptor blockers, calcium channel blockers and angiotensin converting enzyme inhibitors.

Authors: H T Sørensen; L Mellemkjaer; J H Olsen
Journal: Br J Clin Pharmacol Date: 2001-09 Impact factor: 4.335

Depression associated with diltiazem.

1. Organic psychosis caused by diltiazem.

2. A case of Tourette syndrome treated with nifedipine.

3. Diltiazem for tardive dyskinesia and tardive dystonia.

4. Parkinsonism, tardive dyskinesia, akathisia, and depression induced by flunarizine.

5. Nifedipine-induced acute psychosis.

6. Diltiazem and akathisia.

7. Nifedipine-associated acute psychosis.

Review 8. Migraine treatment with calcium channel blockers.

9. Depression associated with nifedipine-induced calcium channel blockade.

10. Parkinsonism, tardive dyskinesia, akathisia, and depression induced by flunarizine.

1. Risk of suicide in users of beta-adrenoceptor blockers, calcium channel blockers and angiotensin converting enzyme inhibitors.

2. Use of calcium channel blockers and risk of suicide. Independent studies are needed before causality is established.

3. The role of the WHO programme on International Drug Monitoring in coordinating worldwide drug safety efforts.

Review 4. A comparative review of the adverse effects of calcium antagonists.

5. Cohort study on calcium channel blockers, other cardiovascular agents, and the prevalence of depression.

Review 6. Assessment and treatment of bipolar disorder in the elderly.

7. Use of calcium channel blockers and risk of suicide: ecological findings confirmed in population based cohort study.

Review 8. Drug-induced depression in the aged. What can be done?

Review 9. Drug-induced depression. Incidence, avoidance and management.

10. General medical with depression drugs associated.